Clinical Trials Logo

Time clinical trials

View clinical trials related to Time.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05256459 Not yet recruiting - Time Clinical Trials

Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma

Start date: May 10, 2022
Phase:
Study type: Observational

This study aims to explore whether there is difference in the incidence rate and incidence rate of HCC in patients with chronic hepatitis B who are screened for high risk of liver cancer. Whether the timely intervention can be used to reduce the incidence of HCC for the early screening and early warning patients can provide evidence-based medical evidence for the selection or adjustment of anti HBV drugs in high-risk patients with liver cancer. To provide evidence for whether patients with liver nodules at high risk of liver cancer need to deal with liver nodules in advance.